- Home
- APC vs FULC Comparison
APC vs FULC Comparison
Compare APC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$8.05
Company Overview
Basic Information| Metric | APC | FULC |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.0M | 718.4M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | APC | FULC |
|---|---|---|
| Price | $18.47 | $8.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $16.38 |
| AVG Volume (30 Days) | 182.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.82 | $2.32 |
| 52 Week High | $19.80 | $15.74 |
Technical Indicators
Market Signals| Indicator | APC | FULC |
|---|---|---|
| Relative Strength Index (RSI) | 67.20 | 36.32 |
| Support Level | N/A | $6.33 |
| Resistance Level | $19.50 | $8.50 |
| Average True Range (ATR) | 0.67 | 0.82 |
| MACD | 0.02 | -0.19 |
| Stochastic Oscillator | 52.53 | 14.19 |
Price Performance
Historical Comparison APC
FULC
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.